Skip to contentS
Skye Bioscience, Inc.
S
SKYESkye Bioscience, Inc. Released May 8, 2020, during market hours
10-Q filed May 8, 2020, 38 days after period end · 0001640334-20-001119
Q1 2020 · 10-Q
Revenue—
Net Income-$2.34M-$2.34MN/M vs Q1 2019N/M vs Q4 2019 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
EPS Diluted
-$0.01-$0.01N/M vs Q1 2019no prior Q4 2019 on file Operating Income-$2,211,208N/M Operating Cash Flow-$1,266,113N/M Free Cash Flowderived-$1,266,113— Filing lag
ended Mar 31, 2020 · filed May 8, 2020 · 38 d after period end